| 000 | 01530 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517053059.0 | ||
| 264 | 0 | _c20160829 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1936-959X | ||
| 024 | 7 |
_a10.3174/ajnr.A4462 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSepahdari, A R | |
| 245 | 0 | 0 |
_aEndolymphatic Hydrops Reversal following Acetazolamide Therapy: Demonstration with Delayed Intravenous Contrast-Enhanced 3D-FLAIR MRI. _h[electronic resource] |
| 260 |
_bAJNR. American journal of neuroradiology _cJan 2016 |
||
| 300 |
_a151-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetazolamide _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 |
_aEndolymphatic Hydrops _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGadolinium DTPA _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImage Enhancement _xmethods |
| 650 | 0 | 4 |
_aImaging, Three-Dimensional _xmethods |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeniere Disease _xdiagnosis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVorasubin, N | |
| 700 | 1 | _aIshiyama, G | |
| 700 | 1 | _aIshiyama, A | |
| 773 | 0 |
_tAJNR. American journal of neuroradiology _gvol. 37 _gno. 1 _gp. 151-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3174/ajnr.A4462 _zAvailable from publisher's website |
| 999 |
_c25272359 _d25272359 |
||